OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung - Durchstechflasche(n) Swissmedic Key 52563038 Registration Holder MSD Merck Sharp & Dohme AG Name OncoTICE, Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung Date of registration 16.11.1994 Introduction of Sequence 16.11.1994 ATC-Classification Bcg Vaccine (L03AX03) Revision date 22.10.2004 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.16.10. Description Stechampulle mit Lyophilisat Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 97.53 Limitation No Deductible 10 % Consumer price 122.50 Feedback FB GTIN 7680525630383 Medication Code Bakterien- und Hefepräparate Pharmacode 2081215 Disponibility ●
Composition Praeparatio cryodesiccata: bacillus Calmette-Guérin (BCG) vivus attenuatum (TICE) 200 - 800 Million CFU, lactosum monohydricum, asparaginum monohydricum, acidum citricum monohydricum, dikalii phosphas anhydricus, magnesii sulfas heptahydricus, ammonii ferri citras, glycerolum, ammonii hydroxidum, zinci formicas, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Pulver zur Herstellung einer Suspension zur intravesikalen Anwendung Excipiens Active Agent Dose Bacillus Calmette-Guérin (Bcg) Vivus Attenuatum (Tice) 200-800
BAG: Active Agent Dose Bacillus Calmette Guerin (Bcg, Tice) 500 Mio U
Inactive agents Citric Acid Monohydrate Ammonii Ferri Citras Ammonii Hydroxidum Asparaginum Monohydricum Dipotassium Phosphate Anhydrate Glycerol Lactose Monohydrate Magnesium Sulfate Heptahydrate Million Cfu Zinci Formicas
Source Data was imported : 07.08.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
